The Contraceptives market in Nicaragua, based on hormones or spermicides, displayed fluctuating trends over the years, reflecting variations in demand and market dynamics. From 2013 to 2023, the market exhibits a growth from $9.4376 million to $12.896 million, showing periodic highs and lows. Notable declines were observed in 2014 (-6.86%) and 2017 (-7.79%), while significant growth occurred in 2015 (16.9%) and 2016 (27.06%). Recent years show a more stabilized trend with marginal changes: a decline in 2022 (-8.32%) followed by a slight recovery in 2023 (0.83%). The five-year compound annual growth rate (CAGR) was modest at 0.76%.
Future trends to watch for include:
- Increased adoption due to educational campaigns on family planning.
- Innovative product developments influencing market preferences.
- Public health policies and funding impacting availability and accessibility.
- Economic factors affecting consumer spending and market penetration.
How does Nicaragua rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 12 | 12 France | 16,955,000 | 2023 | -61.67% | -36.31% | View data |
| 13 | 13 Slovenia | 14,356,000 | 2023 | -0.84% | -0.67% | View data |
| 14 | 14 Nicaragua | 12,896,000 | 2023 | +0.83% | +0.76% | |
| 15 | 15 Greece | 7,403,600 | 2023 | -12.99% | -9.03% | View data |
| 16 | 16 Bulgaria | 6,396,000 | 2023 | -0.93% | -0.79% | View data |